- Home
- CLDX vs RNW Comparison
CLDX vs RNW Comparison
Compare CLDX & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDX | RNW |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United Kingdom |
| Employees | N/A | 4336 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLDX | RNW |
|---|---|---|
| Price | $29.61 | $5.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $46.60 | $7.00 |
| AVG Volume (30 Days) | 644.2K | ★ 829.0K |
| Earning Date | 05-04-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | $11.50 |
| P/E Ratio | ★ N/A | $14.63 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $18.56 | $4.39 |
| 52 Week High | $35.83 | $8.24 |
Technical Indicators
Market Signals| Indicator | CLDX | RNW |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 55.31 |
| Support Level | $28.30 | $5.19 |
| Resistance Level | $30.90 | $5.53 |
| Average True Range (ATR) | 1.52 | 0.21 |
| MACD | -0.48 | -0.00 |
| Stochastic Oscillator | 5.82 | 48.85 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.